A Study of Venetoclax in Combination With Pomalidomide and Dexamethasone in Participants With Relapsed or Refractory Multiple Myeloma
Clinical trial NCT03567616 · TERMINATED
Trial details
- NCT number
- NCT03567616
- Sponsor
- AbbVie
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-10-18
- Primary completion
- 2020-06-18
- Enrollment
- 8
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.